| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |